5% STAKE4582.TTSECAYMAN ISLANDS

Evo Fund lowers stake in SymBio Pharmaceuticals to 31.14%

Stake history

30%32%34%36%38%35.16%Aug 19Aug 19: 35.16% · S100WK0834.55%Aug 29Aug 29: 34.55% · S100WM0H34.44%Sep 10Sep 10: 34.44% · S100WNZ633.74%Sep 25Sep 25: 33.74% · S100WQNY33.20%Oct 17Oct 17: 33.20% · S100WVSV32.80%Oct 29Oct 29: 32.80% · S100WX9T32.27%Nov 17Nov 17: 32.27% · S100X4V231.67%Dec 5Dec 5: 31.67% · S100X8L131.14%Dec 25Dec 25: 31.14% · S100XCSA
30%32%34%36%38%35.16%Aug 19Aug 19: 35.16% · S100WK0834.55%Aug 29Aug 29: 34.55% · S100WM0H34.44%Sep 10Sep 10: 34.44% · S100WNZ633.74%Sep 25Sep 25: 33.74% · S100WQNY33.20%Oct 17Oct 17: 33.20% · S100WVSV32.80%Oct 29Oct 29: 32.80% · S100WX9T32.27%Nov 17Nov 17: 32.27% · S100X4V231.67%Dec 5Dec 5: 31.67% · S100X8L131.14%Dec 25Dec 25: 31.14% · S100XCSA

Summary

Evo Fund and joint holders filed a Change in 5%+ stake (change report) via EDINET on 2025-12-25 14:01 JST concerning SymBio Pharmaceuticals Limited. Reported holding ratio: 31.14%, previous report: 31.67%.

Open the price chart on TradingView.

Source: EDINET S100XCSA ↗ · PDL1.0 · Not investment advice